24/7 Customer Support
Global Bio Pharmaceutical Logistics Market is estimated to witness a rise in revenue from US$ 91.57 Bn in 2021 to US$ 136.63 Bn by 2027. The market is registering a CAGR of 6.5% during the forecast period 2022-2027. Bio pharmaceuticals have become popular as an effective clinical treatment modality for various diseases such as metabolic disorders and cancers. Transportation and storage of these consignments are likely to gain traction across North America, Europe and the Asia Pacific. The demand for temperature monitoring across healthcare and pharmaceuticals sectors will drive the need for advanced storage solutions.
The major factor responsible for the growth of the global bio pharmaceutical logistics market includes the growth of bio pharmaceutical industry and increasing investment in logistics. Growing biopharmaceutical sales coupled with a rapidly increasing biopharmaceutical industry is the primary factor driving the growth of the logistics sector in biopharmaceuticals. Temperature management, protection, safety, conformity with laws and custody chain are the intervention for biopharmaceutical manufacturers at any point from suppliers to distributors. Moreover, logistics is a critical supply chain management component in the bio pharmaceutical industry. The bio pharmaceutical industry opts for logistics to directly handle the acquisition, transportation and movement of resources to end users according to their needs. However, high operational costs restrict the growth in the global bio pharmaceutical logistics market. Also, the power shortage is another problem since bio pharmaceuticals is an energy intensive field. Hence, high running costs are likely to obstruct the market growth.
COVID-19-induced challenges and opportunities in global biopharmaceutical logistics market
The invasion of COVID-19 pandemic has accelerated the demand for biopharmaceutical logistics services. With market developing in response to the outbreak, demand will continue to intensify across advanced and emerging economies. Notably, several companies have upped investment in clinical trials of COVID-19 vaccines. The approval of vaccines will further foster the demand for a seamless supply chain, auguring well for the industry outlook. Temperature-sensitive biopharmaceutical products will continue to gain traction globally. Moreover, while the COVID-19 pandemic has exposed vulnerabilities in the global supply chain of bio pharmaceutical logistics industry, a dramatic surge in the demand for cold chain logistics could boost the growth. Commercialization of innovative drugs and vaccines and investment in R&D will further progress the demand globally.
The study of the Global Bio Pharmaceutical Logistics Market considers various market determinants, industry value chain analysis and competitor analysis of the market. The report discusses the analysis of the bio pharmaceutical logistics industry for the period 2017-2027, where the base year is 2021 and the forecast period is 2022-2027. The report provides a detailed analysis of the Global Bio Pharmaceutical Logistics Market across 15 Chapters and 259 pages. The report includes data presentation across 35 tables and 26 statistical figures.
The report provides PESTLE analysis, which is a tool to examine the external market environment factors that have an impact on the industry. The PESTLE analysis examines the Political, Economic, Social, Technological, Environmental and Legal factors in the external environment. Thus, sufficiently examining the threats and weaknesses of the industry. The research report also provides Porter’s five forces analysis wherein bargaining power of buyers and competitive rivalry is high.
The subsequent section provides details of the market analysis based on different segments such as logistics type, product type, mode of transportation, retail format and region. The report includes detailed study of value chain of the industry. It includes raw material, manufacturing, storage, transportation, distribution and end-users. The report also covers extensively about the key competitors in the market for bio pharmaceutical logistics.
Key Takeaways from the Global Bio Pharmaceutical Logistics Market Report
The Food and Drug Administration (FDA) sets out its standards for the manufacture, storage and distribution of pharmaceutical and food products in the Current Good Manufacturing Practices (CGMP). It covers all the steps in the supply chain, from transport operations, labelling and packaging to personnel training and record-keeping.
The EU has published the Good Distribution Practice of Medical Products for Human Use. The aim of compliance is to maintain the quality and the integrity of medical products. It covers aspects such as quality management systems, personnel, premises and equipment, documentation and qualification of suppliers and customers.
ICH gave guidance for industry stability testing of new drug substances and products describes proper management of temperature excursion in shipping and short-term storage application.
The key players in the Global Bio Pharmaceutical Logistics Market are Deutsche Post DHL, Kuehne+Nagel, DB Schenker, FedEx, Amerisource Bergen, XPO Logistics, Panalpina, Versacold, Agility, DSV and UPS among others. Through extensive research, it is found that big players have adopted various competitive strategies such as mergers & acquisitions in order to have a grip of emerging market. Furthermore, leading companies are expanding their geographical boundaries by acquiring small brands and domestic companies.
Global Bio Pharmaceutical Logistics Market is segmented based on logistics type, product type, mode of transportation, retail format and region in order to get a holistic view of the global marketplace.
Following are the different segments of the Global Bio Pharmaceutical Logistics Market:
By Logistics Type segment of the Global Bio Pharmaceutical Logistics Market is sub-segmented into:
By Product Type segment of the Global Bio Pharmaceutical Logistics Market is sub-segmented into:
By Mode of Transportation segment of the Global Bio Pharmaceutical Logistics Market is sub-segmented into:
By Retail Format segment of the Global Bio Pharmaceutical Logistics Market is sub-segmented into:
By Region segment of the Global Bio Pharmaceutical Logistics Market is sub-segmented into:
|Market Size Value in 2021||US$ 91.57 Bn|
|Expected Revenue in 2027||US$ 136.63 Bn|
|Unit||Value (USD Bn)|
|Segments covered||By Logistics Type, By Product Type, By Mode of Transportation, By Retail Format, By Region|
|Key Companies||Deutsche Post DHL, Kuehne+Nagel, DB Schenker, FedEx, Amerisource Bergen, XPO Logistics, Panalpina, Versacold, Agility, DSV and UPS among others|
|Customization Scope||Get your customized report as per your preference. Ask for customization|
These drugs are increasingly being used in practically all branches of medicine. They have become one of the most effective clinical treatment modalities for various diseases, including cancers and metabolic disorders.
Enhancement in the production rate of biologics, hormone medications, vaccines, complex proteins and temperature-specific by products requiring cold chain shipment has also witnessed significant growth in the bio-pharmaceutical logistics market.
The growth rate of the global bio pharmaceutical logistics market is 6.5%, with an estimated value of US$ 136.63 Billion by 2027.
North America held the major share in terms of revenue, in the global bio pharmaceutical logistics market in 2021.
Factors such growing of bio pharmaceutical industry and increasing investment in logistics drives the growth in the global bio pharmaceutical logistics market.
High operational costs are a restraining factor which inhibits the growth of the market during the forecast period.
Logistics type, product type, mode of transportation, retail format and region are the different segments of the global bio pharmaceutical logistics market.
The air shipping segment are expected to project the highest CAGR over the forecast period as air shipping is the fastest mode of transportation for medical goods with zero loss or product degradation.
China is expected to project the highest CAGR in the Asia Pacific bio pharmaceutical logistics market during the forecast period.
UK held the major share in the Europe market in 2021 driven by surging pharmaceutical production and exports along with the strategic initiatives taken up by the private organization indulged in offering bio pharmaceutical logistics services.
Rapid technological advancements in logistics provides a lucrative growth opportunity in the global bio pharmaceutical logistics market.
The key players operating in the market include Deutsche Post DHL, Kuehne+Nagel, DB Schenker, FedEx, Amerisource Bergen, XPO Logistics, Panalpina, Versacold, Agility, DSV and UPS among others.